Lumos Pharma | NLNK - Aktuelle Verpflichtungen



Aktuelle Verpflichtungen Veränderung Datum
Agenus USD 287.13M 52.57M 2025-09
Alterity Therapeutics Limited AUD 4.38M 849.82K 2023-06
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Capricor Therapeutics USD 28.15M 249K 2025-09
Celldex Therapeutics USD 50.99M 4.53M 2025-12
Cipla INR 62.97B 8.13B 2025-09
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 20.28M 300K 2025-09
CSL USD 4.61B 207M 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Grifols EUR 2.53B 182.67M 2025-09
Incyte USD 1.52B 176.44M 2025-12
Intrexon USD 23.02M 38K 2024-06
Merck USD 28.63B 2.59B 2025-09
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Prothena USD 51.44M 16.37M 2025-09
Sarepta Therapeutics USD 1.1B 173.86M 2025-12